New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy Bodies.
Niels HansenCaroline BouterSebastian Johannes MüllerChristoph van RiesenEya KhadhraouiMarielle ErnstChristian Heiner RiedelJens WiltfangClaudia LangePublished in: Brain sciences (2023)
These biomarker results suggest that MCI-LB is a promising field for the use of biomarkers other than established ones to diagnose early prodromal DLB. Further large-scale studies are needed to better evaluate and subsequently use these promising biomarkers in prodromal DLB.